17/05/2024  21:59:56 Diferencia -0.38 Volumen Bid- Ask- Capitalización de mecado Dividendo A. P/E Ratio
24.97USD -1.50% 6,322
Volumen de negocios: 158,535.68
-Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 273.43 millonesUSD 19.80% 2.74

Descripción de negocio

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven provider of weight-loss and healthy living products and programs. Medifast aims to help customers lead a healthier lifestyle through a holistic approach to weight-loss and weight management, nutrition education and fitness. Medifast's proven results are based on the use of structured meal plans featuring Medifast Meals, which are nutritionally designed to assist customers with successful weight-loss and weight management. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians. The company also offers sports nutrition products under the brand Dual Fuel™ Nutrition that are formulated to provide athletes and active individuals with the right balance of carbohydrates and high quality protein for top performance. Medifast was founded in 1980 and is located in Owings Mills, Maryland.
 

Consejo de gestión & Consejo de supervisión

CEO
Daniel Chard
Consejo de gestión
James Maloney, Claudia Greninger, Jason L. Groves, Esq., Lauren Walker, Nicholas Johnson, Tony Tyree
Consejo de supervisión
Andrea B. Thomas, Constance J. Hallquist, Daniel R. Chard, Jeffrey J. Brown, Kevin G. Byrnes, Michael A. Hoer, Scott Schlackman, Xian Ming
 

Datos de la empresa

Nombre: Medifast Inc.
Dirección: 100 International Drive,Baltimore, Maryland 21202, USA
Teléfono: +1-410-581-8042
Fax: -
E-mail: -
Internet: www.medifast1.com/
Industria: Healthcare
Sector: Pharmaceutical Industry
Subsector: Pharmaceuticals
Fin del año financiero: 31/12
Acciones de libre circulación: 65.90%
Fecha de OPI: -

Relación con inversores

Nombre: Katie Turner
IR teléfono: +1-646-277-1228
IR-fax: -
IR e-mail: -

Accionistas mayoritarios

Freefloat
 
65.90%
BlackRock, Inc.
 
14.70%
The Vanguard Group
 
10.70%
Renaissance Funds
 
8.70%